Skip to content

Pain Management after Caesarean Delivery

Effectiveness of Intravenous Vitamin C as an Adjuvant to Rectal Diclofenac and Intravenous Paracetamol in Pain Management after Caesarean Delivery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202402498343563
Enrollment
164
Registered
2024-02-02
Start date
2021-01-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Cesarean scetion pain

Interventions

Group A
Group B

Sponsors

Promise Ubanatu
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ASA grade I or II Paturients of age 18-40 years. Patients who have given informed written consent. Paturients scheduled to undergo elective Caesarean delivery under subarachnoid block

Exclusion criteria

Exclusion criteria: ASA III or greater Emergency Caesarean delivery. Age more than 40 and less than 18. Patient's refusal to participate in the study Caesarean delivery under General Anaesthesia Patients on pain medications prior to surgery Multiple gestation. Co-existing uterine myoma Patients with history of peptic ulcer disease Pre eclampsia Eclampsia

Design outcomes

Primary

MeasureTime frame
The primary outcomes were the incidence and severity of postoperative pain. Intravenous vitamin C was considered effective as an adjuvant in immediate postoperative pain management when there is a significant difference in the incidence and/or severity of postoperative pain and time to request analgesia between the study groups

Secondary

MeasureTime frame
Side Effects To identify and compare side effects in both groups

Countries

Nigeria

Contacts

Public ContactRoland Okoro

Senior Lecturer at the University of Maiduguri

orolandn@gmail.com+2348032576716

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026